| P50 | author | Melanie Bernstein | Q42605532 |
| | Robert James Hamilton | Q42115758 |
| P2093 | author name string | Fernando Cabrera | |
| | Victor E Reuter | |
| | Paul Russo | |
| | A Ari Hakimi | |
| | Ling Y Chen | |
| | Michael Leapman | |
| | Daniel Morilla | |
| P2860 | cites work | Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis | Q42467738 |
| | Statin use and risk of prostate cancer recurrence in men treated with radiation therapy | Q43084888 |
| | Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy | Q43160142 |
| | Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. | Q43163981 |
| | Is statin use associated with D'Amico risk groups and biochemical recurrence after radical prostatectomy? | Q43525638 |
| | Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans. | Q44677443 |
| | 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis | Q45205118 |
| | Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. | Q46005386 |
| | Statin use and the risk of kidney cancer: a population-based case-control study | Q46134100 |
| | Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients | Q46710487 |
| | Statin use and the risk of 10 cancers. | Q51770029 |
| | The Risk of Cancer in Users of Statins | Q63865877 |
| | Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials | Q29617910 |
| | Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. | Q33626182 |
| | Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma | Q34217704 |
| | Statin use and reduced cancer-related mortality | Q34645107 |
| | Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study | Q35268601 |
| | Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database | Q35282895 |
| | Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts | Q35354232 |
| | Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors | Q36426544 |
| | Statin drugs and risk of advanced prostate cancer | Q36688183 |
| | Statin use and cancer risk in the General Practice Research Database | Q36694570 |
| | Multi-modal treatment for metastatic renal cancer: the role of surgery | Q37724029 |
| | A systematic review and meta-analysis on the therapeutic equivalence of statins | Q37747986 |
| | Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro | Q39820701 |
| | Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma | Q39961148 |
| | Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion. | Q40614837 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 914-919 | |
| P577 | publication date | 2013-11-26 | |
| P1433 | published in | Journal of Urology | Q15709979 |
| P1476 | title | The association between statin medication and progression after surgery for localized renal cell carcinoma | |
| P478 | volume | 191 | |